ClinicalTrials.Veeva

Menu

Neonatal Package Study in Rural District of Pakistan

A

Aga Khan University

Status and phase

Completed
Phase 4

Conditions

Neonatal Infections

Treatments

Other: Essential Neonatal Care
Other: Kangaroo Mother Care
Drug: Chlorhexidine

Study type

Interventional

Funder types

Other

Identifiers

NCT02279381
3106-Ped-ERC-14

Details and patient eligibility

About

Neonatal mortality has been a notable health issue in Pakistan. Considering the importance of the issue and well recognized interventions the investigators are proposing a randomized controlled trial in a rural district of Pakistan which will evaluate the effectiveness of a neonatal package comprised of the standard neonatal care, Kangaroo Mother Care (KMC) and application of chlorhexidine compared with standard neonatal care coupled with application of chlorhexidine and essential neonatal care alone. The investigators anticipate that this study will provide an evidence base way forward benefiting the children of Pakistan.

Full description

The global neonatal mortality burden is one of the imminent factors which derail the achievement of the MDG 4 in many developing countries including Pakistan. Four million infants infants die in their first 28 days of their lives which account for about 40% of the total under-five mortality. The burden of neonatal mortality in Pakistan is alarming as the current neonatal mortality rate (NMR) is 55 per 1000 live births, third worst in the world. The major causes of these deaths are infections, preterm births and birth asphyxia which are avoidable. Despite many initiatives the NMR remains unchanged since last decade in Pakistan.

Literature shows that low cost facility and community based interventions can reduce NMR significantly. Early neonatal care, application of chlorhexidine for cord care and Kangaroo Mother Care (KMC) have been recognized as effective intervention in reduction of neonatal morbidity and subsequently neonatal mortality in many developing countries. However these interventions have never been tested as a package and data about their combined effect is scarce both in Pakistan and developing countries.

Considering the importance of the issue and well recognized interventions we are proposing a randomized controlled trial in a rural district of Pakistan which will evaluate the effectiveness of a neonatal package comprised of the standard neonatal care, KMC and application of chlorhexidine compared with standard neonatal care coupled with application of chlorhexidine and standard neonatal care alone. We anticipate that this study will provide an evidence base way forward benefiting the children of Pakistan.

Enrollment

1,450 patients

Sex

All

Ages

1 to 28 days old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All healthy newborns born in the study settings will be systematically enrolled in the trial after prior consent.

Exclusion criteria

  • Infants with congenital/birth defects,
  • any localized infection on the peri umbilical region at the time of birth or application of
  • any other material such as dung etc before enrollment on the cord.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

1,450 participants in 3 patient groups

Intervention group A
Experimental group
Description:
1. Essential Neonatal Care 2. Kangaroo mother Care 3. Application of 4% Chlorhexidine 4. Education and counseling for mothers and care providers
Treatment:
Drug: Chlorhexidine
Other: Essential Neonatal Care
Other: Kangaroo Mother Care
Intervention group B
Experimental group
Description:
1. Essential Neonatal Care 2. Application of 4% Chlorhexidine 3. Education and counseling for mothers and care providers
Treatment:
Drug: Chlorhexidine
Other: Essential Neonatal Care
Control group
Active Comparator group
Description:
1. Essential Neonatal Care 2. Education and counseling for mothers and care providers
Treatment:
Other: Essential Neonatal Care

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems